Schedule 13G ownership disclosure
Collegium Pharmaceutical Inc
Security class unavailable · CUSIP: 19459J104
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,250,000
- Percent of class
- 3.8800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-117743
- Form type
- SC 13G
- Filer
- COLLEGIUM PHARMACEUTICAL, INC
- CIK
- CIK 1267565
- Filed
- Nov 13, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership